A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3

Clinical trial NCT06273553 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06273553
Sponsor: RinuaGene Biotechnology Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Human Papillomavirus Associated Intraepithelial Neoplasia Cervical Intraepithelial Neoplasia Grade 2/3 Human Papillomavirus Type 16 Infection Human Papillomavirus Type 18 Infection

Start date: 2024-03-01
Primary completion: 2026-10-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.